JPS649571B2 - - Google Patents
Info
- Publication number
- JPS649571B2 JPS649571B2 JP10590679A JP10590679A JPS649571B2 JP S649571 B2 JPS649571 B2 JP S649571B2 JP 10590679 A JP10590679 A JP 10590679A JP 10590679 A JP10590679 A JP 10590679A JP S649571 B2 JPS649571 B2 JP S649571B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- sample
- reagent
- physical property
- analysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000006243 chemical reaction Methods 0.000 claims description 86
- 239000003153 chemical reaction reagent Substances 0.000 claims description 35
- 238000004458 analytical method Methods 0.000 claims description 24
- 230000000704 physical effect Effects 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 5
- 239000000523 sample Substances 0.000 description 39
- 238000000034 method Methods 0.000 description 25
- 239000000126 substance Substances 0.000 description 21
- 238000002835 absorbance Methods 0.000 description 19
- 210000002966 serum Anatomy 0.000 description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 238000005259 measurement Methods 0.000 description 9
- 102000005548 Hexokinase Human genes 0.000 description 8
- 108700040460 Hexokinases Proteins 0.000 description 8
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 8
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 8
- 238000004140 cleaning Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 5
- 229950006238 nadide Drugs 0.000 description 5
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 4
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 3
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 3
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 3
- 102000003929 Transaminases Human genes 0.000 description 3
- 108090000340 Transaminases Proteins 0.000 description 3
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 2
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 229940049906 glutamate Drugs 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- UPLLQJUZZIYKHI-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;2-oxobutanedioic acid Chemical compound OC(=O)CC(=O)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O UPLLQJUZZIYKHI-DFWYDOINSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- 238000009614 chemical analysis method Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 108010067653 lactate dehydratase Proteins 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- -1 phosphate ester Chemical class 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Description
【発明の詳細な説明】
本発明は、分析方法に係り、特に、血清等の多
数の物質の混在する試料中に含まれる目的成分を
定量する自動化学分析装置に用いるに好適な、分
析すべき試料に反応試薬を添加して、誘起される
化学反応によつて生じる物性値の変化から試料中
の目的成分を定量する分析方法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an analysis method, and in particular to an analysis method suitable for use in an automatic chemical analyzer for quantifying target components contained in a sample containing a large number of substances such as serum. The present invention relates to an analysis method for quantifying target components in a sample from changes in physical property values caused by chemical reactions induced by adding a reaction reagent to the sample.
従来の主に臨床検査に使用される自動化学分析
装置では、2つの測定方式が行なわれてきた。即
ち、(1)コレステロールの酵素法による分析や総蛋
白のビユレツト法による分析のように、試料と試
薬の混合後、反応を生じさせ一定時間後に吸光度
を測定する方式で、一般に比色分析法あるいはワ
ンポイント法、エンドポイント法を呼ばれるもの
と、(2)グルタミン酸オキザロ酢酸トランスアミナ
ーゼや乳酸脱水酵素の反応速度追跡法による分析
のように、トリガー試薬添加後の吸光度変化を追
跡する方式で、一般に反応速度測定法、初速度
法、レート分析法あるいはカイネテイツク法と呼
ばれるものである。 Two measurement methods have been used in conventional automatic chemical analyzers mainly used for clinical tests. (1) As in the enzymatic analysis of cholesterol and the analysis of total protein by the Buillet method, this is a method in which a sample and reagent are mixed, a reaction is caused, and the absorbance is measured after a certain period of time; generally, colorimetric analysis or There are two methods called one-point method and end-point method, and (2) methods that track the change in absorbance after the addition of a trigger reagent, such as the reaction rate tracking method for glutamate oxaloacetate transaminase and lactate dehydratase. This method is called the measurement method, initial velocity method, rate analysis method, or kinetic method.
しかしながらこれらの従来の方式では、ビリル
ビンのアゾビリルビン法、グルコースのヘキソキ
ナーゼ法、トリグリセライドのUV法や尿酵窒素
のUV法のような分析化学を適用した場合、試料
中に混在する他物質の影響を簡単には除去でき
ず、それらの影響を除くためには、その大きさを
測らなければならないので、2倍の設備、2倍の
試料と試薬を必要とした。 However, with these conventional methods, when analytical chemistry is applied, such as the azobilirubin method for bilirubin, the hexokinase method for glucose, the UV method for triglycerides, and the UV method for urine enzyme nitrogen, the effects of other substances mixed in the sample cannot be considered. They cannot be easily removed, and their size must be measured in order to remove their effects, so twice the equipment and twice the amount of samples and reagents are required.
ここで更に詳しく例をあげて述べると、血清中
の分析で最も特異性の高い分析法であるヘキソキ
ナーゼ法による分析では、次の(1)式、(2)式の化学
反応が進行する。 To give a more detailed example, in analysis using the hexokinase method, which is the most specific analysis method for serum analysis, the following chemical reactions (1) and (2) proceed.
グルコース+ATPヘキソキナーゼ
――――――――→
グルコース−6−リン酸+ADP ……(1)
グルコース−6−リン酸+NADPG6P−DH
―――――――→
NADPH+b−フオスフオグルクロン酸 ……(2)
ここで、ATPはアデノシントリリン酸、ADP
は、アデノシンジリン酸、NADPは、ニコチン
アミドアデニンデヌクレオチドリン酸エステル、
G6P−DHは、グルコース6フオスフエイトデヒ
ドロゲナーゼ、NADPHは、還元型ニコチンア
ミドアデニンデヌクレオチドリン酸エステルであ
る。Glucose + ATP hexokinase ――――――――→ Glucose-6-phosphate + ADP ……(1) Glucose-6-phosphate + NADPG6P-DH ――――――――→ NADPH + b-phosphoglucuronic acid ……( 2) Here, ATP is adenosine triphosphate, ADP
is adenosine diphosphate, NADP is nicotinamide adenine denucleotide phosphate,
G6P-DH is glucose 6-phosphate dehydrogenase, and NADPH is reduced nicotinamide adenine denucleotide phosphate ester.
この分析化学において、NADPとNADPHの
吸収の相違、即ちNADPHが340nmの吸収ピー
クを持ち、NADPが当該波長において吸収をも
たない事実により、この系での340nmでの吸光
度の変化量はグルコース量に比例する。 In this analytical chemistry, due to the difference in absorption between NADP and NADPH, that is, the fact that NADPH has an absorption peak at 340 nm and NADP has no absorption at that wavelength, the change in absorbance at 340 nm in this system is determined by the amount of glucose. is proportional to.
ここでこの分析化学を前記(1)の比色分析法に適
用した場合、一般の血清試料ではビリルビン等の
色素や濁りの成分等の340nmに吸収をもつ物質
が混在し、それらの影響が大きいため、正確なグ
ルコースの定量ができない。そこで従来の技術で
は前記混在物質の影響の大きさを次のようにして
測定し、除去していた。即ち主分析チヤンネルの
他にもう1つ検体ブランク用の副チヤンネルを設
け、副チヤンネルで妨害物質の影響の大きさを測
定し、それで主チヤンネルのデータを補正する方
式がとられてきた。この場合、機械的に2倍の設
備と、試料量が2倍、その他検体ブランク用の試
薬が必要であつた。又、前にあげた従来技術(2)の
レート分析法では当該反応、前記(1)式、(2)式の化
学反応は非常に速い速度で進み、又温度の影響も
強く受けるために精度よく定量するのがむずかし
いという欠点があつた。 When this analytical chemistry is applied to the colorimetric analysis method described in (1) above, ordinary serum samples contain substances that absorb at 340 nm, such as pigments such as bilirubin and turbidity components, and these have a large influence. Therefore, accurate glucose quantification cannot be performed. Therefore, in the conventional technology, the magnitude of the influence of the mixed substances was measured and removed as follows. That is, a method has been adopted in which a subchannel for a sample blank is provided in addition to the main analysis channel, the magnitude of the influence of interfering substances is measured in the subchannel, and the data of the main channel is corrected accordingly. In this case, twice the mechanical equipment, twice the amount of sample, and other reagents for sample blanks were required. In addition, in the rate analysis method of conventional technology (2) mentioned above, the reaction, the chemical reactions of equations (1) and (2) above, proceed at a very fast rate and are also strongly affected by temperature, so the accuracy is low. The drawback was that it was difficult to quantify accurately.
本発明は、前記従来の欠点を解消するべくなさ
れたもので、試料中に混在する目的成分以外の成
分による妨害の影響を簡単に除去できる分析方法
を提供することを目的とする。 The present invention was made to eliminate the above-mentioned conventional drawbacks, and an object of the present invention is to provide an analysis method that can easily eliminate the interference caused by components other than the target component mixed in a sample.
本発明は、分析すべき試料に反応試薬を添加し
て、誘起される化学反応によつて生じる物性値の
変化から試料中の目的成分を定量する分析方法に
おいて、まず、目的とする反応に必要な成分のう
ち、少なくとも1つを欠いている反応補助試薬を
試料に添加して、第1の物性値を測定し、次い
で、前記反応補助試薬中に含まれなかつた、目的
とする反応に必要な残成分を含むトリガー試薬を
試料に添加して、第2の物性値を測定し、該第2
の物性値を前記第1の物性値で補正して、反応補
助試薬と試料中の目的成分以外との反応による影
響を除くようにして、前記目的を達成したもので
ある。 The present invention is an analysis method in which a reaction reagent is added to a sample to be analyzed, and a target component in the sample is quantified from changes in physical property values caused by the induced chemical reaction. A reaction auxiliary reagent lacking at least one of the components is added to the sample, the first physical property value is measured, and then a reaction auxiliary reagent lacking at least one of the components required for the desired reaction that is not included in the reaction auxiliary reagent is added to the sample. A trigger reagent containing a residual component is added to the sample, a second physical property value is measured, and the second physical property value is measured.
The above object is achieved by correcting the physical property value of the sample with the first physical property value to eliminate the influence of the reaction between the reaction auxiliary reagent and components other than the target component in the sample.
本発明は、ある種の化学分析法では、共存物質
の妨害が大きいことを実験的に確認し、この妨害
を除去する手段として、トリガー試薬添加前と添
加後のトリガーによる反応終了後の物性値、例え
ば吸光度の差が、他の共存物質に起因しない目的
反応のみによる変化量であることに着目してなさ
れたものである。 The present invention has experimentally confirmed that in some types of chemical analysis methods, interference by coexisting substances is large, and as a means to remove this interference, the physical property value after the reaction is determined by the trigger before and after the addition of the trigger reagent. , for example, focusing on the fact that the difference in absorbance is the amount of change due only to the desired reaction and not due to other coexisting substances.
以下、本発明を実施例に基づき詳細に説明す
る。第1図は、本発明の実施例の構成を示す平面
図である。反応テーブル1はその円周上に複数個
(例えば40個)の測定セルを兼ねた反応容器2を
有し、回転軸3を中心に自由に回転できる。試料
テーブル4はその円周上に複数個の試料容器5を
有し、回転軸6を中心に自由に回転できる。試料
のピペツテイングはピペツタ7およびサンプリン
グプローブ8によつて行なわれ、試薬の分注は分
注器9および10によつて行なわれる。分光器1
1は複数検知器による多波長同時測光形であり、
光源ランプ12と相対し、反応テーブル1が回転
状態にある時に反応容器2の列が光源ランプ12
からの光束13を通過するように設置してある。
光束13は反応テーブル1が停止状態にあるとき
に吐出位置25から時計方向に数えて、例えば30番
目の反応容器2の中心を透過するように配置され
ている。光束13の位置と吐出位置25の間には排
液管26および洗清液吐出管27が配置され、そ
れぞれ、排液装置28および洗浄装置29に接続
されている。 Hereinafter, the present invention will be explained in detail based on examples. FIG. 1 is a plan view showing the configuration of an embodiment of the present invention. The reaction table 1 has a plurality (for example, 40) reaction vessels 2 serving as measurement cells on its circumference, and can freely rotate around a rotation axis 3. The sample table 4 has a plurality of sample containers 5 on its circumference and can freely rotate around a rotation axis 6. Pipetting of the sample is performed using a pipette 7 and sampling probe 8, and dispensing of reagents is performed using dispensers 9 and 10. Spectrometer 1
1 is a multi-wavelength simultaneous photometry type using multiple detectors,
The row of reaction vessels 2 faces the light source lamp 12 when the reaction table 1 is in a rotating state.
It is installed so that the light beam 13 from the center passes therethrough.
The light beam 13 is arranged so as to pass through the center of, for example, the 30th reaction vessel 2, counting clockwise from the discharge position 25 when the reaction table 1 is in a stopped state. A drain pipe 26 and a cleaning liquid discharge pipe 27 are arranged between the position of the light beam 13 and the discharge position 25, and are connected to a drain device 28 and a cleaning device 29, respectively.
第2図は本実施例の電気系統を示すブロツク線
図である。電気系全体の構成はマルチプレクサ1
4、対数変換増幅器15、A/D変換器16、中
央処理装置17、読出専用記憶装置18、読出書
込記憶装置19、プリンタ20、操作パネル2
1、機構部駆動回路22から成り立ち、バスライ
ン23で接続されている。 FIG. 2 is a block diagram showing the electrical system of this embodiment. The entire electrical system consists of multiplexer 1
4, logarithmic conversion amplifier 15, A/D converter 16, central processing unit 17, read-only storage device 18, read/write storage device 19, printer 20, operation panel 2
1. It consists of a mechanism drive circuit 22 and is connected by a bus line 23.
以下、図に従つて動作原理を説明する。被測定
試料、例えば血清を収容した試料容器5がサンプ
リング位置31に供給されるとピペツタ7のプロー
ブ8の先端が上記試料容器5内に浸漬され、血清
の一定量を吸入し、プローブ8内に保持する。こ
のとき同時に分注器9は試薬収納容器24から反
応補助試薬を一定量吸入する。その後、プローブ
8は反応テーブル1の吐出位置25まで移動し、吐
出位置25に移送されている反応容器2内にプロー
ブ8で保持していた血清を吐出し、同時に分注器
9により上記反応補助試薬を吐出する。上記の動
作により、被測定試料は反応容器2内で反応補助
試薬と混和して第1の反応を開始する。上記サン
プリング動作が終ると反応テーブル1は時計方向
に間欠的な回転移動を開始し、反応テーブル1上
に反応容器2の全数より1つ多い数の反応容器
2、例えば41個の反応容器2が吐出位置25を通過
するに必要な角度だけ、即ち369度だけ回転して
停止する。上記反応テーブル1の回転によつて上
記サンプリング動作でサンプリングされた試料と
反応補助試薬の入つた反応容器2は吐出位置25よ
り反応容器1ピツチ分即ち角度9度だけ時計方向
に進んだ位置に来て停止していることになる。上
記反応テーブル1の回転中に反応テーブル1上の
全ての反応容器2は光束13を通過する。従つ
て、それぞれの反応容器2が光束13を通過する
ときには分光器11により光吸収測定がなされ、
分光器11の出力はマルチプレクサ14により現
在必要な測定波長の信号が選択され、A/D変換
器16により中央処理装置17に取り込まれて読
出書込記憶装置19に記憶される。上記の反応テ
ーブル1の回転および停止している間の時間を例
えば30秒とすると、30秒を1サイクルとして上記
動作を繰返す。上記サイクルが進むにつれてサン
プリングされた特定の被測定試料は、反応テーブ
ル1が停止している状態での位置が、反応容器1
ピツチ分ずつ時計方向に進んで行く。分注器10
の配管は例えば反応テーブル1の停止状態におい
て、吐出位置25より数えて時計方向に15番目の反
応容器2の上に設置されており、特定の被測定試
料について見ると吐出位置25における補助反応開
始より15サイクル目に分注器10によりトリガー
試薬が添加され目的とする主反応が開始される。
さらにサイクルが進み、反応テーブル1が停止し
ている状態における反応容器2の位置が光束13
を越えて光束13と吐出位置25の間にある反応容
器2内の試料は測定終了の試料であり、排液管2
6を通じて排液装置28により吸引排液される。
また洗浄液吐出管27を通じて洗浄装置29より
洗浄液(通常は蒸留水)が吐出される。次の反応
テーブル1の停止時にこの反応容器2の洗浄液は
上記と同様にして最後の排液が行なわれ、さらに
サイクルが進んで吐出位置25より再度反応容器2
として使用される。以上の動作は読出専用記憶装
置18内のプログラムに従つて中央処理装置17
より機構部駆動回路22を通じて各機構部が制御
される。操作パネル21は測定条件の入力、測定
開始、および測定停止等の操作に使用される。 The operating principle will be explained below with reference to the drawings. When a sample container 5 containing a sample to be measured, for example, serum, is supplied to the sampling position 31, the tip of the probe 8 of the pipette 7 is immersed into the sample container 5, and a certain amount of serum is aspirated into the probe 8. Hold. At the same time, the dispenser 9 sucks a certain amount of the reaction auxiliary reagent from the reagent storage container 24. Thereafter, the probe 8 moves to the discharge position 25 of the reaction table 1, and discharges the serum held by the probe 8 into the reaction container 2 that has been transferred to the discharge position 25, and at the same time, the dispenser 9 is used to assist the reaction. Dispense the reagent. By the above operation, the sample to be measured is mixed with the reaction auxiliary reagent in the reaction container 2, and the first reaction is started. When the above-mentioned sampling operation is completed, the reaction table 1 starts rotating intermittently in the clockwise direction, and the number of reaction vessels 2 that is one more than the total number of reaction vessels 2, for example, 41 reaction vessels 2, is placed on the reaction table 1. It rotates by the angle necessary to pass the discharge position 25, that is, 369 degrees, and then stops. Due to the rotation of the reaction table 1, the reaction container 2 containing the sample sampled in the sampling operation and the reaction auxiliary reagent comes to a position that has advanced clockwise by one pitch of the reaction container, or an angle of 9 degrees, from the discharge position 25. This means that it has stopped. During the rotation of the reaction table 1, all the reaction vessels 2 on the reaction table 1 pass through the light beam 13. Therefore, when each reaction container 2 passes through the light beam 13, light absorption is measured by the spectrometer 11,
From the output of the spectrometer 11, a signal of the currently required measurement wavelength is selected by the multiplexer 14, taken into the central processing unit 17 by the A/D converter 16, and stored in the read/write storage device 19. If the time period during which the reaction table 1 is rotated and stopped is, for example, 30 seconds, the above operation is repeated with 30 seconds as one cycle. As the cycle progresses, the specific sample to be measured is located in the reaction container 1 when the reaction table 1 is stopped.
Go clockwise one pitch at a time. Dispenser 10
For example, when the reaction table 1 is stopped, the piping is installed on the 15th reaction vessel 2 counting clockwise from the discharge position 25, and when looking at a specific sample to be measured, the auxiliary reaction starts at the discharge position 25. At the 15th cycle, a trigger reagent is added by the dispenser 10 to start the desired main reaction.
As the cycle progresses further, the position of the reaction container 2 with the reaction table 1 stopped is the luminous flux 13.
The sample in the reaction vessel 2 that lies between the light beam 13 and the discharge position 25 is the sample for which measurement has been completed;
6, the liquid is sucked and drained by a liquid draining device 28.
Further, a cleaning liquid (usually distilled water) is discharged from the cleaning device 29 through the cleaning liquid discharge pipe 27 . When the next reaction table 1 is stopped, the cleaning liquid in the reaction vessel 2 is drained for the last time in the same manner as described above, and the cycle further advances to the reaction vessel 2 again from the discharge position 25.
used as. The above operations are performed by the central processing unit 17 according to the program in the read-only storage device 18.
Each mechanism is controlled through the mechanism drive circuit 22. The operation panel 21 is used for operations such as inputting measurement conditions, starting measurement, and stopping measurement.
以上の動作で1サイクルにおける反応テーブル
1の停止時間を9.5秒、回転時間20.5秒とすると、
特定試料に着目した場合、その特定試料の反応過
程は29.5秒毎に30回測定され、合計14分45秒間の
測定データが読出書込記憶装置19内に記憶され
ている。中央処理装置17は、読出専用記憶装置
18内のプログラムに従つて作動し、読出書込記
憶装置19内の30個の測定データから予定のプロ
グラムに従つて必要なデータを抽出し、濃度演算
等の処理を行つてプリンタ20に出力する。 With the above operation, if the stop time of reaction table 1 in one cycle is 9.5 seconds and the rotation time is 20.5 seconds, then
When focusing on a specific sample, the reaction process of that specific sample is measured 30 times every 29.5 seconds, and measurement data for a total of 14 minutes and 45 seconds is stored in the read/write storage device 19. The central processing unit 17 operates according to the program in the read-only storage device 18, extracts necessary data from the 30 measurement data in the read/write storage device 19 according to the scheduled program, and performs concentration calculations, etc. The data is processed and output to the printer 20.
実施例 1
ここで前記実施例による装置を、グルコースの
ヘキソキナーゼ法の分析に適用した場合について
述べる。実験結果によれば血清中のグルコースの
ヘキソキナーゼ法による分析の反応経過は第3図
に示すごとく進行する。ここでトリガー試薬はヘ
キソキナーゼ溶液で、反応補助試薬は、前出(1)式
と(2)式におけるATP、NADP、G6P−DHを含
む溶液である。Example 1 Here, a case will be described in which the apparatus according to the above example is applied to analysis of glucose by the hexokinase method. According to the experimental results, the reaction process for analyzing glucose in serum by the hexokinase method proceeds as shown in FIG. Here, the trigger reagent is a hexokinase solution, and the reaction auxiliary reagent is a solution containing ATP, NADP, and G6P-DH in the above formulas (1) and (2).
第3図において示したように、反応液の吸光度
の経時変化は反応時間0点においては試薬のみの
吸光度すなわち試薬ブランクの吸光度aに加え
て、血清自身のもつ共存物質の加わつた吸収を示
す。さらにやはり共存物質により試薬中の
NADPをNADPHに変えるような副反応が短時
間起り、一定の吸光度bに達する。そこで反応時
間7.5分の点で分注器10によりトリガー試薬を
添加すると、前記(1)式、(2)式の反応が起り急速に
進行して、1乃至2分後でほぼ終了して吸光度c
に達する。ここで分析化学的にトリガーであるヘ
キソキナーゼは特異性が高く、グルコースのみに
作用する事実があり、吸光度差(c−b)は血清
中の真のグルコース量に比例する。又、前に述べ
た装置にこの反応を適用した場合、試料移送から
29.5秒ごとに30回測定され、メモリーに記憶され
る。そこで最も簡単には(c−b)は14回目のデ
ータbと30回のデータcの差として求められる。
(b−c)に予定のプログラムにより濃度換算係
数をかけ、プリンター20に出力することができ
る。 As shown in FIG. 3, the change in the absorbance of the reaction solution over time shows the absorbance of only the reagent at the zero point of the reaction time, that is, the absorbance a of the reagent blank, as well as the absorption of the coexisting substances of the serum itself. Furthermore, coexisting substances may cause
A side reaction that converts NADP to NADPH takes place for a short time until a certain absorbance b is reached. Therefore, when the trigger reagent is added using the dispenser 10 at the reaction time of 7.5 minutes, the reactions of equations (1) and (2) occur and proceed rapidly, and almost complete after 1 to 2 minutes, and the absorbance increases. c.
reach. Hexokinase, which is an analytical chemical trigger, has high specificity and acts only on glucose, and the absorbance difference (c-b) is proportional to the true amount of glucose in serum. Also, when this reaction is applied to the device described above, it is possible to
30 measurements are taken every 29.5 seconds and stored in memory. Therefore, most simply, (c-b) can be found as the difference between the 14th data b and the 30th data c.
(b-c) can be multiplied by a density conversion coefficient using a predetermined program and output to the printer 20.
本実施例によれば血清中のグルコースが混在成
分の妨害なく簡単に定量できる。 According to this example, glucose in serum can be easily quantified without interference from mixed components.
実施例 2
ここで前記実施例による装置を、グルタミン酸
オキザル酢酸トランスアミナーゼ(GOT)のレ
ート法による分析に適用した場合について述べ
る。GOTのレート法による分析の反応は次の化
学式(3)式と(4)式で表わされ、又実験結果によれば
血清GOTの反応は第4図に示すごとく進行する。Example 2 Here, a case will be described in which the apparatus according to the above example is applied to analysis of glutamate oxalacetate transaminase (GOT) by the rate method. The reactions of GOT analyzed by the rate method are expressed by the following chemical formulas (3) and (4), and according to the experimental results, the reactions of serum GOT proceed as shown in FIG.
L−アスパラギン酸+α−ケトグルタル酸GOT
――――→
オキザル酢酸+L−グルタミン酸 ……(3)
オキザル酢酸+NADHMDH
―――→
リンゴ酸+NAD
……(4)
ここでMDHは、マレイン酸デイヒドロゲナー
ゼである。L-aspartic acid + α-ketoglutarate GOT ――――→ Oxalacetic acid + L-glutamic acid ……(3) Oxalacetic acid + NADHMDH ――――→ Malic acid + NAD ……(4) Here, MDH is maleate dehydrogenase .
ここでトリガー試薬はα−ケトグルタル酸であ
り、反応補助試薬は(3)式と(4)式におけるL−アス
パラギン酸、NADH、MDHを含む溶液である。 Here, the trigger reagent is α-ketoglutaric acid, and the reaction auxiliary reagent is a solution containing L-aspartic acid, NADH, and MDH in formulas (3) and (4).
第4図において示したように反応液の吸光度は
反応時間0点直後においては、第1試薬と血清の
重なつた吸光度を示す。その後血清中のオキザル
酢酸による(4)式の進行やその他血清中にGOT以
外にNADHを酸化してNADに変える物質が混在
している場合があり、それらのGOT以外の反応
が起り第4図に示すごとく進行する。これらの反
応は検体固有の大きさをもつ、すなわち患者によ
り種々の大きさをもつ。そこで反応時間7.5分の
点で分注器10によりトリガー試薬を添加する
と、前記のGOT反応(3)式とそれに共役してMDH
反応(4)式が起り、第4図に示すごとく吸光度の降
下が起る。ここで従来の方法ではトリガー試薬添
加後の吸光度の単位時間あたりの変化量から
GOTの活性値を求めていたが、血清中にNADH
からNADへ変化させるGOT以外の物質が混在し
ている場合には、それらの副反応が測定値の誤差
となつていた。本実施例では10回目の吸光度デー
タd、14回目の吸光度データをe、16回目の吸光
度データをf、20回目の吸光度データをgとして
{(f−g)−(d−e)}を求め、予定のプログラ
ムにより単位換算係数をかけ、プリンタ20に出
力することができる。 As shown in FIG. 4, the absorbance of the reaction solution shows the overlapped absorbance of the first reagent and serum immediately after the 0 point of reaction time. After that, equation (4) progresses due to oxalacetic acid in the serum, and other substances other than GOT that oxidize NADH to NAD may be present in the serum, and reactions other than GOT occur. The process proceeds as shown below. These reactions have sample-specific magnitudes, ie, they vary in magnitude from patient to patient. Therefore, when the trigger reagent is added using the dispenser 10 at the reaction time of 7.5 minutes, the GOT reaction formula (3) and the MDH are conjugated to it.
Reaction (4) occurs, and the absorbance decreases as shown in Figure 4. Here, in the conventional method, the change in absorbance per unit time after the addition of the trigger reagent is
I was trying to determine the activity value of GOT, but I found that NADH in the serum was not found.
When substances other than GOT, which change from GOT to NAD, are present, these side reactions cause errors in the measured values. In this example, {(f-g)-(d-e)} is calculated by setting the 10th absorbance data to d, the 14th absorbance data to e, the 16th absorbance data to f, and the 20th absorbance data to g. , can be multiplied by a unit conversion coefficient according to a scheduled program and output to the printer 20.
本実施例によれば血清中のGOTが混在成分の
妨害なく簡単に定量できる。 According to this example, GOT in serum can be easily quantified without interference from mixed components.
なお前記実施例においては、いずれも、本発明
がターンテーブルを有する自動化学分析装置に適
用されていたため、従来と同様の自動化学分析装
置において、測定器を追加することなく、単に分
析工程を若干変更するのみで本発明が実施できた
が、本発明の適用範囲はこれに限定されず、フロ
ーセル方式の自動化学分析装置あるいはベルトコ
ンベア方式の自動化学分析装置にも同様に適用で
きることは明らかである。 In each of the above embodiments, the present invention was applied to an automatic chemical analyzer having a turntable, so in a conventional automatic chemical analyzer, the analysis process was simply slightly changed without adding any measuring instruments. Although the present invention was able to be carried out by only making changes, it is clear that the scope of application of the present invention is not limited to this, and can be similarly applied to a flow cell type automatic chemical analyzer or a belt conveyor type automatic chemical analyzer. .
又、前記実施例においては、いずれも、本発明
が、吸光度による分析に適用されていたが、本発
明の適用範囲はこれに限定されず、一般の物性値
を測定して分析する分析方法にも同様に適用でき
ることは明らかである。 In addition, in all of the above examples, the present invention was applied to analysis using absorbance, but the scope of application of the present invention is not limited to this, and is applicable to analysis methods that measure and analyze general physical property values. It is clear that the same applies.
以上説明した通り、本発明によれば、目的成分
に特異性のあるトリガー試薬の添加前と、当該ト
リガー試薬添加後の反応状態から分析するように
したので、目的成分の定量が、混在成分の妨害を
受けることなく簡単に且つ精度良く行なうことが
できるという優れた効果を有する。 As explained above, according to the present invention, analysis is performed from the reaction state before the addition of a trigger reagent specific to the target component and after the addition of the trigger reagent. It has the excellent effect of being able to be easily and accurately carried out without interference.
第1図は本発明に係る分析方法の実施例が適用
される自動化学分析装置の構成を示す平面図、第
2図は前記自動化学分析装置における電気系統を
示すブロツク線図、第3図は本発明が適用される
ヘキソキナーゼ法によるグルコース分析の反応過
程を示す線図、第4図は同じく本発明が適用され
るレート法によるグルタミン酸オキザロ酢酸トラ
ンスアミナーゼ分析の反応過程を示す線図であ
る。
1……反応テーブル、2……反応容器、4……
試料テーブル、5……試料容器、7……ピペツ
タ、8……プローブ、9,10……分注器、11
……分光器、12……光源ランプ、13……光
束。
FIG. 1 is a plan view showing the configuration of an automatic chemical analyzer to which an embodiment of the analysis method according to the present invention is applied, FIG. 2 is a block diagram showing the electrical system in the automatic chemical analyzer, and FIG. FIG. 4 is a diagram showing the reaction process of glucose analysis by the hexokinase method to which the present invention is applied, and FIG. 4 is a diagram showing the reaction process of glutamate oxaloacetate transaminase analysis by the rate method to which the present invention is also applied. 1...Reaction table, 2...Reaction container, 4...
Sample table, 5... Sample container, 7... Pipettor, 8... Probe, 9, 10... Dispenser, 11
... Spectrometer, 12 ... Light source lamp, 13 ... Luminous flux.
Claims (1)
される化学反応によつて生じる物性値の変化から
試料中の目的成分を定量する分析方法において、
まず、目的とする反応に必要な成分のうち、少な
くとも1つを欠いている反応補助試薬を試料に添
加して、第1の物性値を測定し、次いで、前記反
応補助試薬中に含まれなかつた、目的とする反応
に必要な残成分を含むトリガー試薬を試料に添加
して、第2の物性値を測定し、該第2の物性値を
前記第1の物性値で補正して、反応補助試薬と試
料中の目的成分以外との反応による影響を除くよ
うにしたことを特徴とする分析方法。1 In an analysis method in which a reaction reagent is added to a sample to be analyzed and the target component in the sample is quantified from changes in physical property values caused by the induced chemical reaction,
First, a reaction auxiliary reagent lacking at least one of the components necessary for the desired reaction is added to the sample, and the first physical property value is measured. In addition, a trigger reagent containing residual components necessary for the desired reaction is added to the sample, a second physical property value is measured, the second physical property value is corrected by the first physical property value, and the reaction is performed. An analysis method characterized by eliminating the effects of reactions between auxiliary reagents and components other than the target components in the sample.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10590679A JPS5630644A (en) | 1979-08-22 | 1979-08-22 | Method of analysis |
| JP1859090A JPH03198797A (en) | 1979-08-22 | 1990-01-29 | Analyzing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10590679A JPS5630644A (en) | 1979-08-22 | 1979-08-22 | Method of analysis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1859090A Division JPH03198797A (en) | 1979-08-22 | 1990-01-29 | Analyzing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5630644A JPS5630644A (en) | 1981-03-27 |
| JPS649571B2 true JPS649571B2 (en) | 1989-02-17 |
Family
ID=14419907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10590679A Granted JPS5630644A (en) | 1979-08-22 | 1979-08-22 | Method of analysis |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5630644A (en) |
-
1979
- 1979-08-22 JP JP10590679A patent/JPS5630644A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5630644A (en) | 1981-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0041366B1 (en) | Method for operating an apparatus for analysing samples optically | |
| US4612289A (en) | Method for analyzing liquid sample | |
| JPH0224337B2 (en) | ||
| JPH0311663B2 (en) | ||
| JPS5936227B2 (en) | Chemical analysis methods | |
| WO2026016337A1 (en) | Time sequence control method for dry biochemical analyzer, control apparatus, and storage medium | |
| Driscoll et al. | Discrete automated chemistry system with tableted reagents. | |
| JPS649571B2 (en) | ||
| JPH0321062B2 (en) | ||
| JPS6118693B2 (en) | ||
| JPH03198797A (en) | Analyzing method | |
| JPH01182740A (en) | Method for analyzing reaction speed in chemical analysis | |
| JP2727510B2 (en) | Rate analysis method | |
| JPH0287069A (en) | automatic analyzer | |
| JPH0547782B2 (en) | ||
| Halls et al. | Faster determination of chromium in urine by electrothermal atomisation atomic absorption spectrometry | |
| JPS6345055B2 (en) | ||
| JPS6243490B2 (en) | ||
| JPH0146113B2 (en) | ||
| JPS63129998A (en) | Determination of alakaline phosphatase | |
| JPS62298765A (en) | Automatic chemical analysis | |
| JPS6060558A (en) | Analyzing method for plural measurements | |
| JP2001235422A (en) | Automatic analyzer | |
| US3723063A (en) | Process for determination of chemical constituents of proteinaceous biological fluids | |
| JPH0154667B2 (en) |